Miki D - Search Results

1

Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.

Shirane Y, Fujii Y, Ono A, Nakahara H, Hayes CN, Miura R, Murakami S, Sakamoto N, Uchikawa S, Fujino H, Nakahara T, Murakami E, Yamauchi M, Miki D, Kawaoka T, Arihiro K, Tsuge M, Oka S. Shirane Y, et al. Among authors: miki d. Cancers (Basel). 2024 Mar 28;16(7):1328. doi: 10.3390/cancers16071328. Cancers (Basel). 2024. PMID: 38611007 Free PMC article.

2

Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma.

Uka K, Aikata H, Takaki S, Miki D, Kawaoka T, Jeong SC, Takahashi S, Toyota N, Ito K, Chayama K. Uka K, et al. Among authors: miki d. J Gastroenterol. 2007 Oct;42(10):845-53. doi: 10.1007/s00535-007-2099-8. Epub 2007 Oct 15. J Gastroenterol. 2007. PMID: 17940838

3

Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: seven cases.

Uka K, Aikata H, Takaki S, Kawaoka T, Saneto H, Miki D, Takahashi S, Toyota N, Ito K, Chayama K. Uka K, et al. Among authors: miki d. World J Gastroenterol. 2008 Apr 28;14(16):2602-8. doi: 10.3748/wjg.14.2602. World J Gastroenterol. 2008. PMID: 18442216 Free PMC article.

4

Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma.

Miki D, Aikata H, Uka K, Saneto H, Kawaoka T, Azakami T, Takaki S, Jeong SC, Imamura M, Kawakami Y, Takahashi S, Itamoto T, Asahara T, Arihiro K, Chayama K. Miki D, et al. J Gastroenterol. 2008;43(7):550-7. doi: 10.1007/s00535-008-2194-5. Epub 2008 Jul 23. J Gastroenterol. 2008. PMID: 18648742

5

G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection.

Noguchi C, Imamura M, Tsuge M, Hiraga N, Mori N, Miki D, Kimura T, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Tateno C, Yoshizato K, Chayama K. Noguchi C, et al. Among authors: miki d. J Infect Dis. 2009 Jun 1;199(11):1599-607. doi: 10.1086/598951. J Infect Dis. 2009. PMID: 19432545

6

HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice.

Tsuge M, Hiraga N, Akiyama R, Tanaka S, Matsushita M, Mitsui F, Abe H, Kitamura S, Hatakeyama T, Kimura T, Miki D, Mori N, Imamura M, Takahashi S, Hayes CN, Chayama K. Tsuge M, et al. Among authors: miki d. J Gen Virol. 2010 Jul;91(Pt 7):1854-64. doi: 10.1099/vir.0.019224-0. Epub 2010 Mar 10. J Gen Virol. 2010. PMID: 20219897

7

Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.

Mitsui F, Tsuge M, Kimura T, Kitamura S, Abe H, Saneto H, Kawaoka T, Miki D, Hatakeyama T, Hiraga N, Imamura M, Kawakami Y, Aikata H, Takahashi S, Hayes CN, Igarashi H, Morimoto K, Shimizu M, Chayama K. Mitsui F, et al. Among authors: miki d. Antimicrob Agents Chemother. 2010 Aug;54(8):3205-11. doi: 10.1128/AAC.01372-09. Epub 2010 May 24. Antimicrob Agents Chemother. 2010. PMID: 20498322 Free PMC article. Clinical Trial.

8

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.

Abe H, Ochi H, Maekawa T, Hayes CN, Tsuge M, Miki D, Mitsui F, Hiraga N, Imamura M, Takahashi S, Ohishi W, Arihiro K, Kubo M, Nakamura Y, Chayama K. Abe H, et al. Among authors: miki d. J Hepatol. 2010 Sep;53(3):439-43. doi: 10.1016/j.jhep.2010.03.022. Epub 2010 May 31. J Hepatol. 2010. PMID: 20576307

9

HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy.

Hayes CN, Kobayashi M, Akuta N, Suzuki F, Kumada H, Abe H, Miki D, Imamura M, Ochi H, Kamatani N, Nakamura Y, Chayama K. Hayes CN, et al. Among authors: miki d. Gut. 2011 Feb;60(2):261-7. doi: 10.1136/gut.2010.223495. Epub 2010 Nov 10. Gut. 2011. PMID: 21068134

10

IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.

Abe H, Hayes CN, Ochi H, Maekawa T, Tsuge M, Miki D, Mitsui F, Hiraga N, Imamura M, Takahashi S, Kubo M, Nakamura Y, Chayama K. Abe H, et al. Among authors: miki d. J Hepatol. 2011 Jun;54(6):1094-101. doi: 10.1016/j.jhep.2010.09.019. Epub 2011 Feb 4. J Hepatol. 2011. PMID: 21145800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters